The 14-3-3 proteins mediate phosphorylation-dependent protein-protein interactions. Through binding to numerous client proteins, 14-3-3 controls a wide range of physiological processes and has been implicated in a variety of diseases, including cancer and neurodegenerative disorders. To better understand the structure and function of 14-3-3 proteins and to develop small-molecule modulators of 14-3-3 proteins for physiological studies and potential therapeutic interventions, the authors have designed and optimized a highly sensitive fluorescence polarization (FP)–based 14-3-3 assay. Using the interaction of 14-3-3 with a fluorescently labeled phosphopeptide from Raf-1 as amodel system, they have achieved a simple 1-step “mixand-measure” method for analyzing 14-3-3 proteins. This is a solution-based, versatile method that can be used tomonitor the binding of 14-3-3with a variety of client proteins. The 14-3-3 FP assay is highly stable and has achieved a robust performance in a 384-well format with a demonstrated signal-to-noise ratio greater than 10 and a Z• factor greater than 0.7. Because of its simplicity and high sensitivity, this assay is generally applicable to studying 14-3-3/client-protein interactions and especially valuable for high-throughput screening of 14-3-3 modulators.
Fu H, Subramanian RR, Masters SC: 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol2000;40:617-647.
2.
Yaffe MB: How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett2002;513:53-57.
3.
Muslin AJ, Xing H: 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal2000;12:703-709.
4.
Dougherty MK, Morrison DK: Unlocking the code of 14-3-3. J Cell Sci2004;117(Pt 10):1875-1884.
5.
Aitken A, Baxter H, Dubois T, Clokie S, Mackie S, Mitchell K, et al: Specificity of 14-3-3 isoform dimer interactions and phosphorylation. Biochem Soc Trans2002;30:351-360.
6.
Muslin AJ, Tanner JW, Allen PM, Shaw AS: Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell1996;84:889-897.
7.
Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, et al: The structural basis for 14-3-3:phosphopeptide binding specificity. Cell1997;91:961-971.
8.
Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N, et al: 14-3-3-affinity purification of over 200 human phosphoproteins reveals newlinks to regulation of cellularmetabolism, proliferation, and trafficking. Biochem J2004;379(Pt 2):395-408.
9.
Meek SE, Lane WS, Piwnica-Worms H: Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. J Biol Chem2004;279:32046-32054.
10.
Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, et al: Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol2004;14:1436-1450.
11.
Wilker E, Yaffe MB: 14-3-3 proteins: a focus on cancer and human disease. J Mol Cell Cardiol2004;37:633-642.
12.
Hermeking H: The 14-3-3 cancer connection. Nat Rev Cancer2003;3:931-943.
13.
Chen HK, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD, Fernandez MH, et al: Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell2003;113:457-468.
14.
Wang B, Yang H, Liu Y, Jelinek T, Zhang L, Ruoslahti E, et al: Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry1999;38:12499-12504.
15.
Masters SC, Fu H: 14-3-3 proteinsmediate an essential anti-apoptotic signal. J Biol Chem2001;276:45193-45200.
16.
Petosa C, Masters SC, Bankston LA, Pohl J, Wang B, Fu H, et al: 14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem1998;273:16305-16310.
17.
Pozuelo Rubio M, Peggie M, Wong BH, Morrice N, MacKintosh C: 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase. Embo J2003;22:3514-3523.
18.
Arkin MR, Wells JA: Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov2004;3:301-317.
19.
Fotouhi N, Graves B: Small molecule inhibitors of p53/MDM2 interaction. Curr Top Med Chem2005;5:159-165.
20.
Li L, Thomas RM, Suzuki H, DeBrabander JK, Wang X, Harran PG: Asmall molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science2004;305:1471-1474.
21.
Zhang L, Wang H, Liu D, Liddington R, Fu H: Raf-1 kinase and exoenzyme S interact with 14-3-3zeta through a common site involving lysine 49. J Biol Chem1997;272:13717-13724.
22.
Banks P, Gosselin M, Prystay L: Fluorescence polarization assays for high throughput screening of G protein-coupled receptors. J Biomol Screen2000;5:159-168.
23.
Lynch BA, Loiacono KA, Tiong CL, Adams SE, MacNeil IA: Afluorescence polarization based Src-SH2 binding assay. Anal Biochem1997;247:77-82.
24.
Owicki JC: Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J Biomol Screen2000;5:297-306.
25.
Parker GJ, Law TL, Lenoch FJ, Bolger RE: Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligandbinding and kinase/phosphatase assays. J Biomol Screen2000;5:77-88.
26.
Wu P, Brasseur M, Schindler U: Ahigh-throughput STATbinding assay using fluorescence polarization. Anal Biochem1997;249:29-36.
27.
Wu JJ, Yarwood DR, Pham Q, Sills MA: Identification of a high-affinity antiphosphoserine antibody for the development of a homogeneous fluorescence polarization assay of protein kinase C. J Biomol Screen2000;5:23-30.
28.
Jameson DM, Mocz G: Fluorescence polarization/anisotropy approaches to study protein-ligand interactions: effects of errors and uncertainties. Methods Mol Biol2005;305:301-322.
29.
Zhang L, Chen J, Fu H: Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA1999;96:8511-8515.
30.
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al: Current Protocols in Molecular Biology. New York: John Wiley, 1987.
31.
Fu H, Coburn J, Collier RJ: The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family. Proc Natl Acad Sci USA1993;90:2320-2324.
32.
Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen1999;4:67-73.
33.
Truong AB, Masters SC, Yang H, Fu H: Role of the 14-3-3C-terminal loop in ligand interaction. Proteins2002;49:321-325.
34.
van Hemert MJ, van Heusden GP, Steensma HY: Yeast 14-3-3 proteins. Yeast2001;18:889-895.
35.
Ferl RJ: 14-3-3 proteins: regulation of signal-induced events. Physiol Plant2004;120:173-178.
